Feedback / Questions
Vicromax (merimepodib) - BioSig Tech
Coronavirus Vaccine - University of Texas, National Institute of Allergy and Infectious Diseases
http://www.globenewswire.com/news-release/2020/04/21/2019434/0/en/BioSig-Subsidiary-ViralClear-Submits-Application-for-Vicromax-Through-FDA-s-Coronavirus-Treatment-Acceleration-Program-CTAP-to-Seek-Acceleration-of-its-Planned-Clinical-Trials.html
Apr 21, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next